| | | | | - | - | | | |   
                     
| | - | | - | ' '   |     /

  -
  ? 
  ,  
  , ,
  , ,
    ......
   
 
  -.
 
  ...
  
    - 
 
   
  .   
  
  • -
  • BMI
       
     
    ,
    60 -

    >>

    CD73:
    `-
    CD73:
       CD73:
    MGUS:
    `-
    MGUS:
         MGUS:
    ? `.
    ` - . , . , . - , Herceptin -Gleevec, -5 -50% -66%. ...
                  ?  `.
    - ,
     - ,
    Ofatumumab - FDA , `
    `-
    Ofatumumab - FDA , `
    Ofatumumab    - FDA    ,  `
    30 : , `.
    ` - . , -4 " . 2009 -1,479,350 ", 562,340 . , . ...
           30  :       ,  `.
    Iressa:
    `-
    Iressa:
    Iressa:
    -4
    , : , , .
     -4
    - . `.
    ` - . 2007 obesity . , " ...
        - .  `.
    - . `.
    ` - . 2007 obesity . , " ...
        - .  `.
    `
    ` () . Ginsenoside Rg1 ...
    `
    ? `.
    ` - . 389,000 , 3.6% . , , ...
        ?   `.
    ? `
    ` - . 389,000 , 3.6% . , , ...
        ?  `
    ?
    ` - . , , . . ...
                ?
    LOX Lysyl oxidase, ?
    : ` . . (transformation) , ...
     LOX  Lysyl oxidase,         ?
    Dasatinib: ְֶוֹ (CML) -Gleevec.
    ` -
    Dasatinib: ְֶוֹ (CML) -Gleevec.
    Dasatinib:      ְֶוֹ  (CML)  -Gleevec.
    ?
    ` -
    ?
             ?
    , : ...
    - - :
    ` -
    - - :
      -   -      :
    - ...
    :
    - : ` . -Judah Folkman , "-" angiogenesis, "" , ...
         :
    - , . ...
    ,
    :
          ,
    Zebularine: ֶפּ (epigenetic cancer therapy)
    ` -
    Zebularine: ֶפּ epigenetic cancer therapy
    Zebularine:       ֶפּ  (epigenetic cancer therapy)
    -
    `
    -
      -
     1  2 3  >>
    / , , , / , / . .

    ,
    / " .




    | |
    | | | | | | |
    | | | |
    | | | |